About two million people in Germany suffer from osteoarthritis of the joints. Because of the high incidence and the often unsatisfactory outcomes, the need for safe and effective orthopaedic treatment methods is very high. Under the pressure of the increasing annual number of joint operations for osteoarthritis (so-called total endoprosthesis, for short: TEP), as well as other surgical procedures such as arthroscopy, and the resulting cost burden on the healthcare system in Germany, there is a huge need for the expansion of existing as well as new conservative treatment methods.

In other words: For medical procedures for preserving the knee joint without requiring surgery. Enter ORTHOGEN Lab Services GmbH. The EOT®II syringe is used in the context of non-surgical treatment for osteoarthritis and joint problems. The patented process enables the attending physician to produce autologous conditioned serum (for short: ACS) using the EOT®II syringe in the laboratory.


News

  • Orthogen Lab Services Distributionsmeeting Düsseldorf
  • International Distributor’s Meeting in Düsseldorf

    International Distributor’s Meeting in DüsseldorfThe annual International Orthogen Distributor’s Meeting 2017 will take place in Düsseldorf, Germany, from January 19 to 21.The participants from 22 countries and 3 continents will discuss clinical studies, business strategy and other new developments. One key topic will be the recently started International Orthokine Registry to investigate the safety and efficacy […]
    more

  • orthogen-orthokin-moscow
  • ORTHOGEN and Dr. Shikhmetov from Gazprom Dayclininc in Moscow
    work together to better treat Osteoarthritis

    ORTHOGEN and Dr. Shikhmetov from Gazprom Dayclininc in Moscow work together to better treat Osteoarthritis
    more

  • Kooperation_mit_Chiesi_Russland
  • ORTHOGEN kooperiert mit Chiesi Russland
    in Sachen Vermarktung der EOTII-Spritze

    News in Orthopaedics October 26th, 2015, Düsseldorf Cooperation with Chiesi Russia ORTHOGEN Lab Services GmbH and Chiesi Russia have signed a long-term framework agreement for an exclusive cooperation in Russia. The aim of the agreement is to make the products by ORTHOGEN Lab Services GmbH (such as the EOT®II syringe for the preparation of autologous conditioned serum) available […]
    more

  • Orthogen_unterstuetzt_Berliner_Turn-und_Freizeitsport-Bund
  • ORTHOGEN SUPPORTS
    THE BERLINER TURN- UND FREIZEITSPORT-BUND

    News in Orthopaedics  October 22nd, 2015, Berlin  Orthogen supports the Berliner Turn- und Freizeitsport-Bund  On the fringes of the German Congress of Orthopaedics and Traumatology (DKOU) on October 22nd, 2015, in Berlin, Orthogen organised a charity soccer match together with the Bundesliga club Hertha BSC. The Above-40 team of Hertha BSC played orthopaedists and trauma […]
    more

  • ORTH@DKOU2015
  • ORTHOGEN @ DKOU 2015
    New international guidelines for the non-surgical treatment of osteoarthritis

    News in Orthopaedics  October 22nd, 2015, Berlin  Orthogen @ DKOU 2015 New international guidelines for the non-surgical treatment of osteoarthritis were presented at the ORTHOGEN Lunch Symposium ‘Conservative Management of Knee Osteoarthritis’. Strengthening conservative methods for avoiding surgical interventions – under the motto ‘Avoiding surgery, relieving pain, promoting healing’.In Germany, according to experts Peter Wehling […]
    more